STXBP4
Basic information
Region (hg38): 17:54968727-55173632
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STXBP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 0 |
Variants in STXBP4
This is a list of pathogenic ClinVar variants found in the STXBP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-54990825-G-T | not specified | Uncertain significance (Nov 22, 2023) | ||
17-54990843-G-T | not specified | Uncertain significance (Jun 21, 2021) | ||
17-54990850-A-G | not specified | Likely benign (Jul 12, 2022) | ||
17-54990898-C-T | not specified | Uncertain significance (Nov 23, 2022) | ||
17-54990899-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
17-54999351-C-G | not specified | Uncertain significance (Sep 06, 2022) | ||
17-54999352-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
17-54999373-T-G | not specified | Uncertain significance (Mar 04, 2024) | ||
17-54999408-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
17-54999751-C-T | not specified | Uncertain significance (Aug 23, 2021) | ||
17-54999838-G-T | not specified | Likely benign (Oct 30, 2023) | ||
17-55007506-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
17-55007566-C-T | not specified | Uncertain significance (Jun 22, 2023) | ||
17-55007571-C-T | not specified | Uncertain significance (Apr 16, 2024) | ||
17-55031192-C-A | not specified | Uncertain significance (Mar 20, 2023) | ||
17-55031239-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
17-55047149-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
17-55073012-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
17-55073044-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
17-55073051-T-C | not specified | Uncertain significance (Jan 17, 2024) | ||
17-55078108-A-G | not specified | Uncertain significance (Mar 02, 2023) | ||
17-55078117-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
17-55081103-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
17-55081178-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
17-55141310-G-T | not specified | Uncertain significance (Jul 11, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STXBP4 | protein_coding | protein_coding | ENST00000376352 | 16 | 195559 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.52e-14 | 0.227 | 125657 | 0 | 90 | 125747 | 0.000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.736 | 241 | 275 | 0.875 | 0.0000137 | 3575 |
Missense in Polyphen | 47 | 63.718 | 0.73763 | 851 | ||
Synonymous | 1.69 | 74 | 95.0 | 0.779 | 0.00000446 | 1046 |
Loss of Function | 1.15 | 25 | 32.0 | 0.781 | 0.00000152 | 426 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000598 | 0.000595 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.000664 | 0.000653 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000329 | 0.000325 |
Middle Eastern | 0.000664 | 0.000653 |
South Asian | 0.000535 | 0.000523 |
Other | 0.000167 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the translocation of transport vesicles from the cytoplasm to the plasma membrane. Inhibits the translocation of SLC2A4 from intracellular vesicles to the plasma membrane by STX4A binding and preventing the interaction between STX4A and VAMP2. Stimulation with insulin disrupts the interaction with STX4A, leading to increased levels of SLC2A4 at the plasma membrane. May also play a role in the regulation of insulin release by pancreatic beta cells after stimulation by glucose (By similarity). {ECO:0000250}.;
- Pathway
- Insulin Signaling;Insulin-mediated glucose transport;Validated transcriptional targets of deltaNp63 isoforms
(Consensus)
Recessive Scores
- pRec
- 0.0911
Intolerance Scores
- loftool
- 0.880
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0386
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stxbp4
- Phenotype
Gene ontology
- Biological process
- protein targeting;cellular response to DNA damage stimulus;insulin receptor signaling pathway;regulation of glucose transmembrane transport;positive regulation of keratinocyte proliferation;protein stabilization;regulation of insulin secretion involved in cellular response to glucose stimulus;cellular response to interferon-gamma;positive regulation of cell cycle G1/S phase transition
- Cellular component
- phagocytic vesicle;extracellular exosome
- Molecular function
- protein binding;syntaxin binding